203 related articles for article (PubMed ID: 37210571)
21. Changes over Time and Responsiveness of the Cochin Hand Function Scale and Mouth Handicap in Systemic Sclerosis Scale in Patients with Systemic Sclerosis: A Prospective Observational Study.
Nguyen C; Bérezné A; Mestre-Stanislas C; Lefèvre-Colau MM; Rannou F; Guillevin L; Mouthon L; Poiraudeau S
Am J Phys Med Rehabil; 2016 Dec; 95(12):e189-e197. PubMed ID: 27584140
[TBL] [Abstract][Full Text] [Related]
22. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.
Chan PT; Mok CC; Chan KL; Ho LY
Clin Rheumatol; 2014 May; 33(5):659-66. PubMed ID: 24531870
[TBL] [Abstract][Full Text] [Related]
23. Functional Disability among Systemic Sclerosis Patients: Relation to Disease Characteristics and Quality of Life Parameters.
Zaghlol RS; Dawa GA; Makarm WK
Curr Rheumatol Rev; 2022; 18(3):257-265. PubMed ID: 34847844
[TBL] [Abstract][Full Text] [Related]
24. The association between hand disease severity and fatigue in individuals with systemic sclerosis: a scoping review.
Krause D; Poole JL; Khanna D; Murphy SL
Disabil Rehabil; 2022 Oct; 44(20):5827-5833. PubMed ID: 34388047
[TBL] [Abstract][Full Text] [Related]
25. Differences in patients with systemic sclerosis recruited from associations and tertiary care settings.
Mestre-Stanislas C; Poiraudeau S; Berezné A; Rannou F; Pagnoux C; Revel M; Guillevin L; Mouthon L
Presse Med; 2010 Sep; 39(9):e205-9. PubMed ID: 20356709
[TBL] [Abstract][Full Text] [Related]
26. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis.
Abignano G; Mennillo GA; Lettieri G; Karadag DT; Carriero A; Padula AA; Del Galdo F; Khanna D; D'Angelo S
J Rheumatol; 2021 Sep; 48(9):1422-1426. PubMed ID: 33452163
[TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Khanna D; Hays RD; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Fathi N; Bechtel A; Furst DE
Arthritis Rheum; 2009 Sep; 61(9):1257-63. PubMed ID: 19714600
[TBL] [Abstract][Full Text] [Related]
28. Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey.
Frantz C; Avouac J; Distler O; Amrouche F; Godard D; Kennedy AT; Connolly K; Varga J; Matucci-Cerinic M; Allanore Y
Semin Arthritis Rheum; 2016 Aug; 46(1):115-23. PubMed ID: 27132536
[TBL] [Abstract][Full Text] [Related]
29. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
[TBL] [Abstract][Full Text] [Related]
30. The Italian version of the Mouth Handicap in Systemic Sclerosis scale (MHISS) is valid, reliable and useful in assessing oral health-related quality of life (OHRQoL) in systemic sclerosis (SSc) patients.
Maddali Bongi S; Del Rosso A; Miniati I; Galluccio F; Landi G; Tai G; Matucci-Cerinic M
Rheumatol Int; 2012 Sep; 32(9):2785-90. PubMed ID: 21847653
[TBL] [Abstract][Full Text] [Related]
31. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.
Steen VD; Medsger TA
Arthritis Rheum; 1997 Nov; 40(11):1984-91. PubMed ID: 9365087
[TBL] [Abstract][Full Text] [Related]
32. Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration.
Matsuda KM; Sugimoto E; Ako Y; Kitamura M; Miyahara M; Kotani H; Norimatsu Y; Hisamoto T; Kuzumi A; Fukasawa T; Sato S; Yoshizaki A
J Dermatol; 2024 Jun; 51(6):741-751. PubMed ID: 38558171
[TBL] [Abstract][Full Text] [Related]
33. Results of the Health Assessment Questionnaire for Japanese patients with systemic sclerosis--measuring functional impairment in systemic sclerosis versus other connective tissue diseases.
Morita Y; Muro Y; Sugiura K; Tomita Y; Tamakoshi K
Clin Exp Rheumatol; 2007; 25(3):367-72. PubMed ID: 17631731
[TBL] [Abstract][Full Text] [Related]
34. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis.
Lee TH; Lee JS; Park S; Lee KA; Kim HS
Korean J Intern Med; 2021 Nov; 36(6):1504-1514. PubMed ID: 33561335
[TBL] [Abstract][Full Text] [Related]
35. Development of a new patient-reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17-item Scleroderma Functional scale.
Daste C; Abdoul H; Foissac F; Papelard A; Alami S; Kwakkenbos L; Carrier ME; Lefèvre-Colau MM; Thombs BD; Poiraudeau S; Rannou F; Mouthon L; Nguyen C
Br J Dermatol; 2020 Oct; 183(4):710-718. PubMed ID: 32017013
[TBL] [Abstract][Full Text] [Related]
36. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
37. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
Mouthon L; Rannou F; Bérezné A; Pagnoux C; Guilpain P; Goldwasser F; Revel M; Guillevin L; Fermanian J; Poiraudeau S
Arthritis Rheum; 2008 Jul; 59(7):968-73. PubMed ID: 18576298
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.
McMahan ZH; Frech T; Berrocal V; Lim D; Bruni C; Matucci-Cerinic M; Smith V; Melsens K; Proudman S; Zhang J; Mendoza F; Woods M; Khanna D
J Rheumatol; 2019 Jan; 46(1):78-84. PubMed ID: 30442827
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
